MedTrace Logo

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

NCT02777268 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-12-02

Study results available
· View outcomes & findings →

Summary

This was a single centre, open-label, randomised, 5-way crossover study.

Conditions

  • Healthy Subjects

Interventions

DRUG

Infacort

Multi-particulate granules

DRUG

Hydrocortisone

Tablet

Sponsors & Collaborators

  • Simbec Research

    collaborator INDUSTRY

  • Neurocrine UK Limited

    lead INDUSTRY

Principal Investigators

  • Girish Sharma, MD · Simbec Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02777268 on ClinicalTrials.gov